Marshall Wace
LEGN icon

Marshall Wace’s Legend Biotech LEGN Stock Holding History

Marshall Wace’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.84M Sell
202,227
-84,896
-30% -$2.29M ﹤0.01% 1289
2026
Q1 		$5.19M Sell
287,123
-468,830
-62% -$8.94M 0.01% 1288
2025
Q4 		$16.4M Buy
755,953
+738,081
+4,130% +$21.1M 0.02% 699
2025
Q3 		$583K Buy
17,872
+4,189
+31% +$155K ﹤0.01% 2169
2025
Q2 		$486K Sell
13,683
-366,381
-96% -$11.9M ﹤0.01% 2158
2025
Q1 		$12.9M Buy
380,064
+18,502
+5% +$664K 0.02% 674
2024
Q4 		$11.8M Sell
361,562
-132,805
-27% -$5.5M 0.01% 738
2024
Q3 		$24.1M Buy
+494,367
New +$26.3M 0.03% 456
2023
Q1 		– Sell
-37,125
Closed -$1.85M – 2909
2022
Q4 		$1.85M Buy
+37,125
New +$1.8M ﹤0.01% 1772
2022
Q2 		– Sell
-128,290
Closed -$4.66M – 3667
2022
Q1 		$4.66M Sell
128,290
-258,583
-67% -$10.2M 0.01% 1422
2021
Q4 		$18M Buy
+386,873
New +$19.6M 0.03% 533
2021
Q3 		– Sell
-141,375
Closed -$5.8M – 3251
2021
Q2 		$5.8M Buy
141,375
+117,753
+498% +$4M 0.03% 761
2021
Q1 		$686K Buy
+23,622
New +$644K ﹤0.01% 1815
2020
Q3 		– Sell
-12,614
Closed -$537K – 1773
2020
Q2 		$537K Buy
+12,614
New +$493K ﹤0.01% 1178

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Marshall Wace's LEGN Position: Q2 2026 in Review

Marshall Wace reduced its Legend Biotech (LEGN) stake by 30% in Q2 2026, selling an estimated $2.29M and leaving 202,227 shares worth $5.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1289.

Marshall Wace first reported a position in LEGN in Q2 2020 and has held it in 14 quarters since. The position peaked at $24.1M in Q3 2024. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Marshall Wace held 202,227 shares of Legend Biotech worth $5.84M as of Q2 2026.
  • Marshall Wace sold 84,896 Legend Biotech shares in Q2 2026, an estimated $2.29M.
  • Legend Biotech made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1289 holding.
  • Marshall Wace first reported a position in Legend Biotech in Q2 2020 and has held it in 14 quarters since.
  • Marshall Wace's Legend Biotech position peaked at $24.1M in Q3 2024.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.